603 related articles for article (PubMed ID: 19412870)
1. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis.
Shulman JP; Latkany P; Chin KJ; Finger PT
Ocul Immunol Inflamm; 2009; 17(2):95-100. PubMed ID: 19412870
[TBL] [Abstract][Full Text] [Related]
2. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis.
Tannen BL; Ghesani NV; Frohman L; Eichler JD; Maldjian PD; Chu DS
Ocul Immunol Inflamm; 2008; 16(1):25-7. PubMed ID: 18379938
[TBL] [Abstract][Full Text] [Related]
3. Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size.
McCannel TA; Reddy S; Burgess BL; Auerbach M
Retina; 2010 Jan; 30(1):146-51. PubMed ID: 20010323
[TBL] [Abstract][Full Text] [Related]
4. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
[TBL] [Abstract][Full Text] [Related]
7. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
10. [The usefulness of whole body FDG-PET/CT in patients with brain metastasis].
Nakagawa K; Aoyagi M; Inaji M; Maehara T; Toriyama H; Kawano Y; Tamaki M; Nariai T; Ohno K
No Shinkei Geka; 2009 Feb; 37(2):159-66. PubMed ID: 19227157
[TBL] [Abstract][Full Text] [Related]
11. The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis.
Doycheva D; Deuter C; Hetzel J; Frick JS; Aschoff P; Schuelen E; Zierhut M; Pfannenberg C
Br J Ophthalmol; 2011 Sep; 95(9):1290-4. PubMed ID: 20935307
[TBL] [Abstract][Full Text] [Related]
12. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
13. Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis.
Scheler J; Rehani B; Percy T; Pelstring R; Bharija A; Ames D; Mantil J
Clin Nucl Med; 2008 Apr; 33(4):280-1. PubMed ID: 18356670
[TBL] [Abstract][Full Text] [Related]
14. Sarcoidosis as a benign cause of lymphadenopathy in cancer patients.
Hunt BM; Vallières E; Buduhan G; Aye R; Louie B
Am J Surg; 2009 May; 197(5):629-32; discussion 632. PubMed ID: 19321155
[TBL] [Abstract][Full Text] [Related]
15. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG PET-CT findings of intraperitoneal carbon particles-induced granulomas mimicking peritoneal carcinomatosis.
Lim ST; Jeong HJ; Kim DW; Yim CY; Sohn MH
Clin Nucl Med; 2008 May; 33(5):321-4. PubMed ID: 18431143
[TBL] [Abstract][Full Text] [Related]
17. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
Kurli M; Chin K; Finger PT
Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064
[TBL] [Abstract][Full Text] [Related]
18. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT.
Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]